These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 6290045)

  • 21. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast.
    Hilson JB; Schnitt SJ; Collins LC
    Am J Surg Pathol; 2010 Jun; 34(6):896-900. PubMed ID: 20463570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions.
    Pavlakis K; Zoubouli C; Liakakos T; Messini I; Keramopoullos A; Athanassiadou S; Kafousi M; Stathopoulos EN
    Breast; 2006 Dec; 15(6):705-12. PubMed ID: 16384708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of immunohistochemical probes in the study of benign and malignant breast disease.
    Gusterson BA; Warburton MJ; Monaghan P; Foster C; Edwards P; Kraft N; Smith C; Mitchell D; Rudland PS; Neville AM
    Behring Inst Mitt; 1984 May; (74):39-48. PubMed ID: 6383328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical localization of collagens and fibronectin in human breast neoplasms.
    al Adnani MS; Taylor S; al-Bader AA; al-Zuhair AG; McGee JO
    Histol Histopathol; 1987 Jul; 2(3):227-38. PubMed ID: 2980725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.
    Pellegrino MB; Asch BB; Connolly JL; Asch HL
    Cancer Res; 1988 Oct; 48(20):5831-6. PubMed ID: 2458830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of stromal protein and integrin expression in breast--a marker of premalignant change?
    Jones JL; Critchley DR; Walker RA
    J Pathol; 1992 Aug; 167(4):399-406. PubMed ID: 1383484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state.
    Rudland PS; Leinster SJ; Winstanley J; Green B; Atkinson M; Zakhour HD
    J Histochem Cytochem; 1993 Apr; 41(4):543-53. PubMed ID: 8450194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
    Bratthauer GL; Saenger JS; Strauss BL
    Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of invasion in breast lesions using antibodies to basement membrane components and myoepithelial cells.
    Raymond WA; Leong AS
    Pathology; 1991 Oct; 23(4):291-7. PubMed ID: 1664512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
    Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
    Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
    Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
    J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical staining patterns of type VI collagen in the normal, hyperplastic, and neoplastic adult male breast.
    Magro G; Lanzafame S; Colombatti A
    Pathologica; 1994 Apr; 86(2):142-5. PubMed ID: 7936755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential tissular expression and localization of type IV collagen alpha1(IV), alpha2(IV), alpha5(IV), and alpha6(IV) chains and their mRNA in normal breast and in benign and malignant breast tumors.
    Nakano S; Iyama K; Ogawa M; Yoshioka H; Sado Y; Oohashi T; Ninomiya Y
    Lab Invest; 1999 Mar; 79(3):281-92. PubMed ID: 10092064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural distinctions among human breast epithelial cells revealed by the monclonal antikeratin antibodies AE1 and AE3.
    Sorenson SC; Asch BB; Connolly JL; Burstein NA; Asch HL
    J Pathol; 1987 Oct; 153(2):151-62. PubMed ID: 2447254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast.
    Egan MJ; Newman J; Crocker J; Collard M
    Arch Pathol Lab Med; 1987 Jan; 111(1):28-31. PubMed ID: 3026280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tubular carcinoma of the breast. Clinical, histological, and ultrastructural observations.
    Tobon H; Salazar H
    Arch Pathol Lab Med; 1977 Jun; 101(6):310-6. PubMed ID: 193458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ductal carcinoma of the breast. Electron microscopic study].
    Mroczka B; Domaniewski J
    Patol Pol; 1989; 40(2):171-9. PubMed ID: 2561607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer.
    Nerlich AG; Wiest I; Wagner E; Sauer U; Schleicher ED
    Anticancer Res; 1997; 17(6D):4443-9. PubMed ID: 9494547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nodular sclerosing adenosis (adenosis tumor) of the breast. An immunohistologic study particularly in reference to the relationship with radial cicatrix and to the differential diagnosis with tubular carcinoma].
    Lanzafame S
    Pathologica; 1989; 81(1073):251-66. PubMed ID: 2641538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions.
    Dalal P; Shousha S
    Mod Pathol; 1995 May; 8(4):413-6. PubMed ID: 7567941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.